327 - Malignant Hyperthermia Is Your Facility Prepared
Description: Clinical Issue Malignant Hyperthermia (MH) complicates 1:100,000 adult surgical cases. MH is triggered when inhaled anesthetics and Succinylcholine are used together, as a result delay in treatment increases complications of an MH crisis. Early recognition of an MH crisis and prompt emergency response is critical for maximum patient survival. Critical consideration in the administration of Dantrolene is necessary as it is the only clinically available drug to treat MH. Description of Team An MH crisis impacts the entire perioperative team. Preparation and Planning Emergency preparedness in following the MHAUS poster and having an available stocked MH cart ready are key in life saving efforts. Assessment Early recognition of MH symptoms MH symptoms/ manifestations include ETCO2>55mmHg; PaCO2.60mmHg, unexplained sinus tachycardiac, ventricular tachycardia or ventricular fibrillation, metabolic acidosis (Base deficit > 8m/Eql, ph 20,000/L units; cola colored urine; excess myoglobin in urine or serum; plasma [K+] >6mEq/L, rapidly increasing temperature; T>38.8 degrees Celsius. Implementation Implement use of a stocked readily available MH cart with a process to check outdates. Cart should include, medications, supplies for cooling the patient, supplies for anesthesia. Outcome Minimize patient harm and prevent patient mortality by having supplies and medications at fingertips Implications Implications for Perioperative Nursing ability to quickly mobilize and treat the patient with MH.